Albumin solution    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
20Adrenoleukodystrophy1

20. Adrenoleukodystrophy    [ 49 clinical trials,   86 drugs,   (DrugBank: 29 drugs),   18 drug target genes,   112 drug target pathways]
Searched query = "Adrenoleukodystrophy", "Adrenomyeloneuropathy", "AMN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 49 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04303416
(ClinicalTrials.gov)
March 9, 20206/3/2020Plasma Exchange With Albumin in AMN PatientsEffect of Plasma Exchange With Albumin in Patients With Adrenomyeloneuropathy: Unicentric, Single Arm, Proof of Concept Study.Adrenomyeloneuropathy;AdrenoleukodystrophyDrug: Albumin solutionOnofre, Aurora Pujol, M.D.NULLNot yet recruiting18 Years65 YearsMale5Phase 2;Phase 3Spain